New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed retail prices of 37 formulations under the Drugs…
New Delhi: In a significant regulatory action reinforcing the strict demarcation between cosmetics and drugs, the Central Drugs Standard Control Organization (CDSCO) has cancelled the import registration of the cosmetic…
New Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO) has opined that Ekam Pharma should submit the globally approved PI/ reference document for…
Hyderabad: The Telangana High Court recently refused to grant relief to a postgraduate medical aspirant, who challenged the local candidate eligibility criteria prescribed in the National Eligibility Entrance Test Postgraduate (NEET…
Hyderabad: Aurobindo Pharma has announced that CuraTeQ Biologics Private Limited, a wholly owned subsidiary of the Company, has mutually agreed to terminate its agreement with BioFactura Inc, USA relating to…
New Delhi: The Calcutta High Court has passed an interim injunction in a trademark infringement and passing-off suit filed by Himalaya Global Holdings Ltd and another against Shimla Drugs Health…
A new study published in the journal of Diseases found a significant association between vitamin D deficiency and diabetic nephropathy (DN) in patients with type 2 diabetes mellitus (T2DM). The patients…
USA: Researchers have reported that low-dose combined hormonal contraceptives (CHCs) can effectively control symptoms of polycystic ovary syndrome (PCOS) without increasing the burden of metabolic syndrome in women with hyperandrogenic…
China: Researchers have found in a new study that a short inpatient course of personalized acoustic therapy may enhance long-term tinnitus remission in adults with idiopathic sudden sensorineural hearing loss…
New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has accepted the Phase IV clinical trial report for Lenvatinib Capsules 4 mg and 10…